BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease — BIVA-pilot

Angina Pectoris, Variant Clinical Trial

Official title:
BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease: Pilot Study

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02932553
Study type	Interventional
Source	Asan Medical Center
Contact
Status	Withdrawn
Phase	Phase 4
Start date	April 19, 2017
Completion date	April 19, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02845531` - Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death	Phase 4
Withdrawn	`NCT02790528` - Statin Therapy In Patients With Vasospastic Angina	Phase 4
Active, not recruiting	`NCT01318629` - Angina in Non Coronary Artery Disease	N/A
Recruiting	`NCT05618132` - ReACHallenge Trial: Acetylcholine Rechallenge After Pretreatment With Vasoactive Drugs	N/A
Recruiting	`NCT00620204` - Efficacy Study of Atorvastatin to Treat Variant Angina	Phase 4
Active, not recruiting	`NCT03477890` - Coronary Microvascular Function and CT Coronary Angiography (CorCTCA)	N/A